RxDoctor Payments Data

Antonio Ferrey, MD

Family Medicine · Orange, CANPI 1750417549

Payments from drug & device makers

$4,326in general payments, 2019–2025

Across 231 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$523
  • Lilly USA, LLC$517
  • Johnson & Johnson$387
  • AstraZeneca$337
  • GSK$314
  • Boehringer Ingelheim$272
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$4,30399%
  • Gifts$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,326 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$34,724
Medicare patients
88
Services billed
355

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin74$101,413
JanuviaSitagliptin Phosphate76$78,742
RybelsusSemaglutide21$36,284
FarxigaDapagliflozin Propanediol23$28,205
OzempicSemaglutide14$15,664
TrulicityDulaglutide11$10,258
Atorvastatin Calcium721$7,006
MyrbetriqMirabegron11$6,232
Levothyroxine Sodium338$4,600
Metformin Hcl438$3,929
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$3,421
Losartan Potassium275$3,096
Rosuvastatin Calcium164$2,960
Omeprazole196$2,835
Albuterol Sulfate HfaAlbuterol Sulfate58$2,459

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$272$101,41374 claims
MerckJanuvia$178$78,74276 claims
Novo NordiskRybelsus, Ozempic$523$51,94935 claims
AstraZenecaFarxiga$337$28,20523 claims
Lilly USA, LLCTrulicity, Humalog$517$12,29723 claims
Astellas Pharma US IncMyrbetriq$34$6,23211 claims
AbbVieSynthroid$96$2,05346 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →